Fig. 3From: CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomyPrognostic impact of preoperative CA19-9 levels of stage III GC patients with (a) or without (b) postoperative adjuvant chemotherapy (PAC)Back to article page